Drug intelligence / Profile preview

desonide

Development stage
Approved
Lead developer
Dow
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Desonide is a synthetic nonfluorinated corticosteroid used topically as a low-potency anti-inflammatory agent. It is primarily indicated for the symptomatic treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic dermatitis (eczema), seborrheic dermatitis, contact dermatitis, and psoriasis in both adults and children[1][2][3][4][5][8]. As a topical corticosteroid, desonide exerts anti-inflammatory, antipruritic (anti-itch), and vasoconstrictive effects. The mechanism of action involves binding to cytosolic glucocorticoid receptor; this complex then migrates to the cell nucleus where it modulates gene expression by activating or repressing specific genes. Corticosteroids are thought to induce phospholipase A2 inhibitory proteins (lipocortins), which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting arachidonic acid release from membrane phospholipids[4][8]. The precise mechanism for its clinical effect in skin conditions remains unclear[6].

Brand names
DesOwenDesonateTridesilonVerdesoLokaraDesrx
Other names
desonide sodium diphosphatedesonide sodium phosphate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on desonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call